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Abstract
Topographies promote surface-dependent behaviors which may positively influence peri-implant 
bone healing. In this study the topological effects of TiO2 nanotubes (TNTs) on aspects of 
preosteoblast behavior was investigated. Specifically, we hypothesize that TNTs can influence cell 
proliferation of preosteoblasts through cell adhesion and related modulation of FAK and RhoA. 
By culturing MC3T3-E1 cells on TNTs with different diameters (40nm and 150nm diameters), 
topography-dependent modulation in cell morphology and cell growth were observed. The 
average spreading area of the cell on Flat Ti, 40nm TNTs and 150nm TNTs were respectively 
2176.05 μm2, 1510.44 μm2 and 800.72 μm2. Proliferation increased among cells cultured on the 
150nm TNTs (28.6%) compared with on Flat Ti (17.06%). The expression of FAK was 86.2% 
down regulated superimposition of TNTs topography. RhoA expression only slightly decreased 
(45.9%). Increasing TNT diameter enhanced initial adherent cell growth, which was relevant to 
the increased RhoA-to-FAK ratio in the cell. Increased TNT diameter was associated with higher 
ratio and greater proliferation in the first 24 hours. These findings not only support our hypothesis, 
but suggest that RhoA might be critically involved in TNTs mediated cell proliferation. Future 
investigation using functional gain and loss of RhoA may further reveal its mechanism.
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Model for FAK-RhoA modulation of topography-regulated proliferation.
1. Introduction
The increased concern about the interaction between implant surfaces and osteoblasts has 
led the research on implant surface topography cues to new areas. The ideal implant surface 
should not only promote early adhesion of osteoblasts, but more importantly, should also 
facilitate cell proliferation, which subsequently helps provide the precondition for bone 
formation. The creation of a material that can meet all these conditions is challenging. 
Compared with micro and macro-topography, surfaces with a more defined, reliable and 
reproducible nanostructure roughness provide a more conducive environment for osteoblast 
function in vivo.1 Due to the advantageous high surface-to-volume ratio as well as higher 
degree of biocompatibility, titanium dioxide nanotubes (TNTs) are of particular interest.2,3 
Cell activity is directed by cell-implant surface interactions and a series of subsequent 
intracellular cascades would be triggered by the material topography.4 The response of 
preosteolasts to TNTs has been mainly reflected in different cell behaviors, such as 
adhesion, morphology, proliferation, migration, survival, and differentiation.5 Recently, it 
has been found that 70–100nm diameter TNTs might control the degrees of cell adhesion.6–8 
However, the related information about how they affect bioactivities of cells still remains 
lacking.
The interaction between cells and an inert substrate (no chemical leaching) is initiated by the 
formation of focal adhesion (FA), which leads to sequential arrangement of the actin 
cytoskeleton as well as mechanotransduction within the cells. These cellular cascades yield 
varied levels of gene and protein expression that contribute to activating or deactivating 
related signal pathways.4 Focal adhesion kinase (FAK) - a cytoplasmic tyrosine kinase 
which localizes in focal contacts - is an essential mediator in ECM/integrin signaling 
transduction pathways.9,10 FAK-dependent pathways have been associated with cell survival 
and cell cycle11. The influential role of FAK in cell proliferation has been reported in 
numerous studies.12–14 Overexpressed FAK is thought to enhance the transcriptional 
activities of cyclin D1 (cell cycle regulator).15 Nevertheless, the expression of FAK is not 
necessarily required for cell proliferation since FAK RNAi treated cells and FAK−/− cells 
both showed notable proliferation rates.16 Hence, the modulatory role of FAK in ECM/
integrin-regulated proliferation appears to be bifunctional, and depends on other molecular 
signaling pathways that modulate the formation of focal adhesion complex.13
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RhoA functions downstream of integrin signaling and directs the realignment of cells under 
mechanical stretch-induced stimuli by reorganization of cytoskeleton.17 Meanwhile, it is 
noteworthy that RhoA and its downstream effector Rho-associated kinase (ROCK) has been 
shown to contribute to mediating cell growth regulation at the level of cell-cycle machinery 
in terms of signal transduction, say promoting role in cell cycle progression.18,19 While 
FAK and RhoA both can affect cell proliferation, the complementary relationship between 
them was proposed by an earlier biological study.13 Sequentially, whether the same 
phenomenon could be traced by biophysical stimuli (e.g., nanotopography) to induce cell 
proliferation, and whether there is proportional relation existing between the expression of 
FAK and RhoA has not been explored.
2. Materials and methods
To test our hypothesis whether TNTs affect the proliferation of preosteoblasts associated 
with FAK/RhoA, all experiments were carried out on Flat Ti as control group, and 40nm 
TNTs or 150nm TNTs fabricated using two different voltages respectively. For outcome 
assessment, we investigated the adherent cell morphology, cell proliferation, and the protein 
expression of FAK, pY397-FAK and RhoA. The relative level of RhoA to FAK was 
measured by densitometry analysis of the immunoblots. To determine the effects of pY397-
FAK and RhoA on cell growth, FAK Y397 and RhoA inhibitors were applied to cultured 
cells. The osteogenic response of the adherent cells to different surface topographies was 
monitored by gene expression analysis.
2.1 Sample preparation
TNT arrays were prepared according to previous studies via an electrochemical anodization 
method.20,21 Titanium (Ti) foils (99.7%, 0.25mm thick, Sigma-Aldrich, St. Louis, MO, 
USA) were cut into 1cm2 and 4cm2 squares to fit 24-well plates and 6-well plates (Corning, 
NY, USA) for cell culture, respectively. Prior to the anodization, the samples were polished 
to remove the natural oxide layer using 600 and 1200 grit silicon carbide abrasive paper 
disks and sonicated with acetone, 70% ethanol and distilled water sequentially for 15min 
each. After cleaning, the air-dried Ti samples were connected to an electrochemical reaction 
flask having a two-electrode configuration: a platinum foil (Alfa Aesa, Ward Hill, MA, 
USA) cathode and the Ti anode. The cathode and anode were connected to a DC power 
supply. In order to create nanotubes on Ti surface, 10 or 30 volts were applied and 
nanotubes were generated in a glycerol based electrolyte with 0.25 wt % ammonium 
fluoride (96%, Alfa Aesar, Ward Hill, MA, USA) and 2 vol% deionized water. The 
anodized samples were then washed with deionized water, dried at 80°C and heat-treated at 
500°C with a muffle furnace (Thermolyne 6000, Waltham, MA USA) for 3 h to transform 
amorphous titanium oxide (TiO2) nanotubes to crystalline anatase. The samples used for all 
experiments were sterilized with 70% ethanol and UV light overnight prior to use. The 
polished and non-anodized Ti plates were used as the control (Flat Ti). The Flat Ti was 
cleaned, dried and sterilized with the same process as the experimental samples (TNTs made 
of 10v and 30v voltage).
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To observe the effects of TNTs on cell behaviour, MC3T3-E1 mouse preosteoblasts (ATCC, 
Washington, DC) were cultured in regular medium: alpha-minimum essential medium 
(αMEM) with 10% fetal bovine serum and 1% penicillin / streptomycin (PS) under 37°C, 
5% CO2 environment. Cells were seeded onto the control and experimental substrates that 
were placed within polystyrene culture plates. The culture media was changed every 3 days. 
In order to investigate if FAK and RhoA play a role in cell growth, 500nM PF573228 
(Sigma-Aldrich, St. Louis, MO, USA) and 200ng/ml C3 (Cytoskeleton, Hoboken, NJ, USA) 
were respectively22,23 used to inhibit FAK phosphorylation at Y397 and RhoA activity. 
10μM Rock inhibitor Y27632 24 was also applied to confirm the role of RhoA on cell 
proliferation.
2.3 Scanning electron microscopy observation
Surface characterization of the specimens and the adhered MC3T3-E1 cells were conducted 
with SEM (Hitachi S-4700 Cold Cathode Field Emission Scanning Electron Microscope, 
Tokyo, Japan). A 10 kV accelerating voltage was chosen for SEM analysis and the 
secondary electrons were captured with an in-lens detector, and surfaces were rendered at 
magnification of 30,000 and 50,000.
2.4 Cell cycle analysis
Based on the BrdU result of MC3T3-E1 cells cultured on three substrates with regular 
media, the analysis of cell cycle during early culture stage was performed with FACS. 
MC3T3-E1 cells (2.5 × 104/ml) were placed on each of the three substrates for 24 hours 
(n=2). After incubation, the cells were trypsinized and washed with ice-cold PBS, 
centrifuged at 2000 rpm for 5 min and fixed with 2.5 mL 70% ice-cold ethanol at 4°C for 24 
h. Cells were washed again after fixation, and resuspended in 500 μL PBS solution 
containing 0.05 mg/mL propidium iodide (PI) and 0.2 mg/mL RNAse, and then incubated at 
4°C for 2 h. Fluorescence was measured with a FACSCanII flow cytometer, using PE ×FL2 
channels. The assay was carried out in three independent experiments and 10,000 events 
were analyzed per experiment using the FlowJo software.
2.5 BrdU Cell proliferation Assay
The BrdU assay was carried out to test the proliferation level of the cells cultured with the 
regular medium (control group) and the condition medium respectively contained FAK 
inhibitor and RhoA activity inhibitor. Cells (2.5×104/ml) were seeded on 1cm × 1cm Flat Ti 
and TNTs samples, which were placed in 24-well plates. At Day 1 and 7, cells were treated 
with BrdU (BD Biociences, San Jose, US) for 2 hours and then fixed with 4% formaldehyde 
(Tousimis®, Rockville, US) for 1h. The samples were then incubated with monoclonal 
mouse anti-BrdU primary antibody at 4°C overnight, followed by biotinylated goat anti-
mouse IgG (H+L) secondary antibody (Invitrogen, Carlsbad, CA, USA) for 60min and 
DAPI for 15min. The proliferation level was indicated by the ratio of BrdU labeled cell to 
the adhered cell (DAPI) on each sample (n=6). All cells were visualized using a Nikon 
fluorescence microscope with TRITC and DAPI filters, and a Nikon Eclipse Ti-U digital 
camera (Nikon Instruments, Melville, NY). Nikon NIS Elements software was used to 
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acquire the fluorescent merged image and the images were processed and analyzed with 
Image J.
2.6 Cell morphology
To detect the morphology change of MC3T3-E1 cells on different substrates, Focal 
Adhesion Staining Assay was applied to the cells cultured with regular media. Cells (2.5 × 
103/ml) were seeded on 1cm × 1cm Flat Ti and TNTs samples placed in 24-well plates. At 
the end of the 12h culture, the cells were first fixed in 4% formaldehyde for 15 min, then 
permeabilized with 0.1% Triton X100 (Sigma-Aldrich, St. Louis, MO, USA) for 15 min 
followed by blocking in 1% bovine serum albumin (Gibco, Gran Island, NY, USA) for 
30min. Primary antibody incubation was carried out at 4°C overnight, while vinculin, F-
actin and nuclear were counterstained, respectively, for 1h and 15min with Actin 
Cytoskeleton and Focal Adhesion Staining Kit (Millipore, Billerica, MA, USA). Both 
primary and secondary antibodies were diluted in 1% bovine serum in phosphate buffered 
saline (PBS). The vinculin, F-actin phalloidin and DAPI stains were observed with a Nikon 
fluorescence microscope with TRITC, FITC and DAPI filters. All the images were acquired 
with a Nikon Eclipse Ti-U digital camera (Nikon Instruments, Melville, NY) and the merged 
fluorescent images were acquired and analyzed by Nikon NIS Elements software. More than 
80 cells on each sample were measured (n=6). The length to width aspect ratio was used to 
indicate the elongation of the cell, and the area of single cell spreading was obtained with an 
automatic optical threshold defined by the software. The cell elongation and area were 
compared among different tube diameters.
2.7 Protein isolation and Western Blot analysis
The expression of FAK, RhoA, phosphorylated FAK, was examined with Western Blot 
analysis. Cells (2.5 × 104 cell/ml) with 2ml growth medium were cultured per well on 
2cm×2cm flat Ti and TNTs samples placed in 6-well plates 24h prior to harvest. Cells were 
lysed in 1×RIPA buffer (Cell Signaling, Danvers, MA, USA) with protease and phosphatase 
inhibitors (Sigma-Aldrich, St. Louis, MO, USA). The supernatant collected after 
centrifuging for 15 min at 14,000 rpm and 4°C. Protein concentration of cell lysate was 
detected by using the Bradford method with Pierce® BCA Protein Assay Kit (Thermo 
Scientific, Tewksbury, MA, USA). The protein concentration was equalized by diluting with 
lysis buffer, and then all cell lysates were fractionated by electrophoresis in 10% 
polyacrylamide gels and electrotransferred to polyvinylidene difluoride (PVDF) film. After 
blocking with 5% w/v bovine serum albumin (BSA) solution in TBS-T (10mM Tris, 
150mM NaCl, 0.05% v/v Tween 20), the blots were exposed to rabbit antibodies specific to 
mouse FAK (Cell Signaling, Danvers, MA, USA), phosphorylated FAK (pY397) (Cell 
Signaling, Danvers, MA, USA) and RhoA (Sigma-Aldrich, St. Louis, MO, USA). After 
reacting with secondary antibodies (Vector Laboratories, UK), immunoreactive bands were 
visualized using enhanced chemiluminescence detection and quantified using densitometry 
analysis with Imagequant LAS4000 software (GE Healthcare, Cleveland, Ohio, USA). The 
ratio of RhoA/FAK expression was calculated from densitometric values. Blots were 
stripped and reprobed for the loading control of GAPDH (Cell Signaling, Danvers, MA, 
USA). Immunoblots were carried out from four independent individual experiments (n=4). 
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The mean and standard deviation of GAPDH-normalized intensities were calculated with 
Image J.
2.8 Measurement of RhoA activity
RhoA activity was examined with G-LISA™ RhoA activation assay kit (Cytoskeleton, Inc., 
Denver, CO). According to the manufacturer’s instructions, the cell lysates were obtained 
from MC3T3-E1 cells cultured on three substrates and the protein concentration was 
equalized to 1.5 mg/ml for assay. The cell extracts were transferred into a 96-well plate 
which was coated with Rho-GTP binding protein. The inactive GDP-bound Rho was 
removed afterwards through the washing steps. A specific RhoA antibody and an HRP-
conjugated secondary antibody were applied to detect the bound active RhoA and the 
luminescence was read on microplate reader (Molecular Devices LLC, Sunnyvale, CA, 
USA).
2.9 Quantitative real-time PCR
According to the cell proliferation result at late culture stage, the osteogenic gene markers 
were detected to test whether there was an alteration of cell fate. Cells (2.5 × 104/ml) were 
seeded on 2cm × 2cm flat Ti and TNTs samples, which were placed in 6-well plates. The 
expression levels of osteogenesis related genes were measured using the quantitative reverse 
transcription polymerase chain reaction (qRT-PCR). RNA was extracted using TRIzol® 
Reagent (Invitrogen, Carlsbad, CA, USA) at days 4, 7, 14, and 21 after seeding. An 
equivalent amount of RNA from each sample was reverse transcribed into complementary 
DNA (cDNA) using the iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, 
CA, USA). The qRT-PCR analysis of genes including Runt-related transcription factor 
2(Runx2), bone sialoprotein (BSP), Osterix (Osx) and osteocalcin (OCN) were performed 
on the Applied Biosystems 7500 (Applied Biosystems, Foster City, CA, USA) using the Taq 
DNA Polymerase (Invitrogen, Carlsbad, CA, USA). Specific primers were used for each 
target gene (Table 1). The expression levels of the target genes were normalized to that of 
the housekeeping gene GAPDH (n=4).
2.10 Statistical analysis
Numerical data were analyzed with Multi-factorial Analysis of Variance and a non-linear 
regression of different protein expressions (BrdU = α0 + α1 FAK + α2 RhoA + α3 RhoA/
FAK) was used to predict factors influencing cell proliferation. Statistical difference was 
considered at p < 0.05. All experiments were completed three times with three replicates 
used for each experiment.
3. Results
3.1 Fabrication of titanium nanotubes and cell morphology
Nanotubes of different pore size were evenly distributed after anodization and annealing 
treatment and the robust and discrete shape of the nanotopology was confirmed by SEM 
images (Figure 1). Nanotubes of 40nm and 150 nm diameters were found after 3h 
anodization with 10v and 30v voltage (Figure 1B, 1C), respectively, while the control 
titanium foil (Flat Ti) showed no nanotopography (Figure 1A). The TNTs made using 10v 
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and 30v were not highly ordered or aligned. MC3T3 cells cultured on the control titanium 
foil showed wide spreading and more flat morphology and less noticeable filopodia (Figure 
1D). On the contrary, cells on the 40nm and 150nm nanotubes showed greater spatial shape 
with filopodia and lamellipodia extensions (Figure 1E & F) after 12h culture. The elongation 
of MC3T3 cells on 150nm diameter nanotubes was confirmed by immunofluorescent 
staining of vinculin and F-actin (Figure 2). On Flat Ti substrates, more visualized focal 
contacts (green vinculin-binding spots) were found distributed at the edge of the cells; less 
staining was observed in 40nm TNTs and the least staining was found on the 150nm TNTs 
(Figure 2A,2B). The adherent cells on larger TNTs exhibited extraordinary cellular 
protrusion whereas their spreading area presented significant reduction (Figure 2C). The 
elongation was more than twice as much as on the Flat Ti surface, and 1.5 times greater than 
that of the 40nm nanotube (Figure 2D). All observations in morphological changes assessed 
by SEM and staining were similar.
3.2 Cell cycle and proliferation
The BrdU assay and the cell cycle analysis were both performed to observe the change of 
cell proliferation level at early stage. Flow cytometric analysis demonstrated changes in cell 
cycle progression on three substrates (Figures 3A). As shown in Figure 3B, TNTs increased 
the number of cells in S-phases compared with Flat Ti (6.62%), and such elevated S-phase 
proportion was most obvious in 150nm TNTs (25.04%). Moreover, no significant increase 
was found in G2/M phase for the cells grown on TNTs.
Figure 4A showed the images of BrdU immunofluorescence staining for the cells cultured 
on Day 1. The average number of BrdU labeled cell to total adhered cell on Flat Ti, 40nm 
TNTs and 150nm TNTs were respectively 17.06%, 18.58% and 28.6% within 24h (Figure 
4B). However this ratio dropped down to 16.78%, 14.41% and 11.61% after 7days culture. 
Although the cell growth was repressed at both time points and for all three substrates after 
the FAK Y397 phosphorylation was inhibited, the cells on 150nm TNTs still presented 
higher proliferation level (20.17%) during the first 24 hours.
The cells treated with C3 showed greatest reduced proliferation rate in all groups at 1 and 7 
days but with the most remarkable declination being found in 150nm TNTs group (Figure 
4). When C3 and PF573228 were both applied, the cell growth was inhibited in TNTs 
groups, which were not only reflected by cell count of BrdU staining but also confirmed by 
fluorescent intensity. Relatively speaking, C3+ and C3+ PF573228 group appeared to have 
almost the same low level of cell growth except for the control condition at day one. To 
detect the effects of ROCK inhibitor on cell proliferation, we further treated the cells with 
Y27632 for 24 hours in all groups. As shown in Figure S1, the cell growth also appeared 
significant declination, especially in 150nm TNTs group.
3.3 FAK, pY397-FAK, RhoA Protein Expression and RhoA activity
Based on the Focal Adhesion Staining and proliferation result, the expression of FAK and 
RhoA on TNTs were compared with that on Flat Ti. Western blot result of total FAK, 
phosphorylated FAK (pY397-FAK), RhoA and GAPDH showed prominent difference after 
1 day culture (Figure 5A). FAK protein expression in 40nm and 150nm TNTs group were 
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respectively 50.1% and 86.2% less than Flat Ti group (Figure 5B). Meanwhile, the pY397-
FAK expressed at a lower level on TNTs as well (Figure 5C), which was consistent with that 
of total FAK expression. The cells cultured on TNTs performed significantly decreased 
RhoA activity as shown in Figure 5D, though the difference between 40nm and 150nm 
TNTs was not obvious. Activation of RhoA in larger TNTs group declined to 63.12 ± 1.5% 
compared with on Flat Ti. On 150nm TNTs, while the protein level of RhoA also decreased 
(Figure 5E), the relative expression of RhoA compared with FAK was found significantly 
higher (Figure 5F). The densitometry analysis of the RhoA/FAK ratio: 1.38 on Flat Ti, 1.22 
on 40nm TNTs and 3.08 on 150nm TNTs. The non-linear regression analysis showed that 
RhoA/FAK ratio was the most significant factor (p=0.0017) relating to cell proliferation. 
FAK or RhoA alone was not related to proliferation (p>0.05) (Table 2).
3.4 Osteogenic gene expressions
The osteodifferentiation of the cells on three substrates was detected at the late culture stage. 
Runx2, BSP, Osx and OCN were assessed by the qRT-PCR and the expression of all these 
osteogenesis markers showed significant difference over time (Figure 6). TNTs of different 
diameter triggered higher gene levels compared with Flat Ti. Generally, 150nm TNTs 
induced the highest mRNA expression for all these osteogenic genes.
4. Discussion
A prominent effect of altered substrate nanotopography is reflected by the change of cell 
morphology, and recent studies also presented the similar result.2,6,25 Compared with the 
40nm TNTs, the 150nm TNTs promoted the adherent cells to be less spread and have a more 
elongated morphology. Topography-induced cellular behavior is aroused by a mechanical 
force transducer-focal adhesions (FAs),26 through which the geometric inputs from ECM are 
delivered and translated into the formation of intracellular cytoskeleton. One key event in 
FA assembly is the focal adhesion kinase (FAK) which act as signaling “hubs” in FA 
complex network. The physical structure of ECM and cell/biomaterial interaction regulate 
the phosphorylation of FAK at Y397. Since the visualized focal contacts were diminished on 
150nm TNTs, we hypothesized that the FAK or phosphorylated FAK expression is impaired 
by nanotopography due to the reduction of total contact surface available. Our result of 
western blot showed a significant reduction in the expression of total FAK as well as 
pY397-FAK, which were consistent with earlier studies using TCPS or PLLA for a different 
nanoscale of gratings and pits.27,28
Further influence of topography was observed at the level of proliferation. Increased cell 
proliferation was observed at early stages in culture among cells adherent to 150nm TNTs as 
corroborated by Flow cytometry analysis and BrdU immunochemistry staining. The 
increased proportion of S phase as well as the absence of G2/M phase accumulation 
illustrated higher proliferation level in these cells. It is likely that the alterations in FA 
number and / or FAK phosphorylation that occurred as a function of TNT dimension plays a 
key role in regulating proliferation.
Changing TNT diameter led to coordinated, inverse changes in measured cell proliferation. 
Concurrently, reduced numbers of Focal contacts and FAK expression was observed. While 
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FAK plays a prominent part in regulation of proliferation13,14 and its phosphorylation status 
is related to topography induced cell behavior,4 we further explored whether the reduced 
phosphorylated FAK (pY397-FAK) level led to the proliferation change on 150nm TNTs in 
both early and late stage of cell culture. When the pY397-FAK inhibitor was added to 
cultures, PF573228 down regulated cell proliferation on all the three substrates and time 
points, whereas on 150nm TNTs, proliferation remained at relatively higher levels (20.17%) 
during the first 24 hours. In this respect, it is tempting to speculate that the relatively high 
proliferation during the early stage on large TNTs was due to either the multifaceted 
function of FAK or other potential compensation signaling pathways.
RhoA has been suggested to play a compensatory role in providing a permissive condition 
for cell proliferation in FAK−/− cells whose adhesive condition is deficient13. The 
nanotubular topography impeded total FAK expression and the outcome might be analogous 
to the situation of FAK knock down. In this investigation, we explored the potential 
compensatory role of RhoA in regulation of cell proliferation where FAK stimulus was 
apparently reduced. However, using a pharmacological approach, Yang found that slightly 
decreased RhoA expression could increase proliferation in poorly adhering cells.29 Our 
results that RhoA activity is inversely proportional to cell proliferation are also consistent 
with earlier studies.30 The treatment of cells adherent to 150nm TNTs with the RhoA 
inhibitor effectively influenced proliferation, and the similar result was also observed when 
using ROCK inhibitor. While there are measureable reductions of FAK in cells adherent to 
both 40nm and 150 nm TNTs, only on 150 nm TNTs was the ratio of RhoA/FAK 
significantly altered (Figure 5E). The relatively greater influence of C3 versus PF573228 on 
proliferation suggests that the higher RhoA/FAK ratio may be important in resolving these 
multiple intracellular signals. Suggested is a specified role of the relative expression of 
RhoA compared with FAK, which can be regulated by substrates in a topography dependent 
manner, perhaps can be traced back to the topography-induced restrictions imposed by cell 
shape and cytoarchitecture.
In addition, to further investigate the complementary role of RhoA in FAK related cell 
growth, cells were treated with both PF573228 and C3. Cell proliferation was eliminated 
and pY397-FAK inhibition failed to rescue the cell growth. Multi-factorial Analysis of 
Variance confirmed that RhoA inhibition had more prominent negative effects than the 
blockage of FAK autophosphorylation. Our findings were consistent with the biological 
theorem demonstrated in an earlier study.13
Moreover, we also tested the osteodifferentiation capability of MC3T3-E1 cells cultured on 
TNTs substrates. Compared with flat Ti, the osteogenetic marker gene has been remarkably 
promoted 4 days after MC3T3 cells were cultured on 150nm TNTs. The process of 
osteogenic differentiation was solely induced by topographical cue, since no chemical 
treatment was adopted. These results were in agreement with earlier studies.31–33 The 
proliferation and differentiation process of the cell do not occur simultaneously, and the cell 
functional maturation only happens after cell growth.34 Therefore, the enhanced osteogenic 
cell fate and function could be the main reason for the declined proliferation level 3 days 
after seeding on bigger size TNTs. Our limited data, however, cannot directly prove the 
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promotion of mineralization by TNTs; future studies with mineralization assays may 
uncover the RhoA/FAK derived osteogenic effect.
Another limitation of the present study is the lack of investigation of the effects of TNTs 
density and orientation on cell behaviour and other integrin mediated pathways, such as Src, 
Ras, PI3K, and Rac. Because of FAK serves as the “hub” of intracellular 
mechanotransduction and RhoA works as an essential downstream factor of FAK, we, 
therefore, focus on the expression and function of FAK and RhoA in response to TNTs. Our 
outcome is to be carefully interpreted without considering other relative pathways.
Taken together, the nanotubular topography impeded the total FAK expression and the 
outcome might mimic the situation of FAK knocking down, in which process other 
compensatory factors, such as RhoA, may consequently rescue cell proliferation.
5. Conclusions
The TNTs had noticeable effects on MC3T3-E1 cells behavior, not only in cell morphology 
but also cell proliferation. In this study, we found that MC3T3-E1 cell proliferation can be 
affected by TNTs, and the promotion of cell growth at early stage triggered by such 
topographical factor are observed to be associated with RhoA and FAK. This phenomenon 
works more prominent for TNTs with larger diameter, and the relatively high RhoA/FAK 
ratio is proposed to contribute more to this observation than the impeded FAK expression. 
Future studies will delineate more about the mechanism of FAK and RhoA involvement, as 
well as the interaction of their activity in nanotopography regulated cell behavior, and 
provide a basis for manipulating and the use of nanostructure in artificial orthopedic 
implant.
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Scanning electron microscopy (SEM) observation of TNTs morphology and MC3T3-E1 
cells attachment. (A) Flat Ti, (B) 40nm TNTs and (C) 150nm TNTs. Adherent MC3T3-E1 
cells on Flat Ti (D), 40nm TNTs (E) and 150nm TNTs (F). For enlarged sections the scale 
bars equals 0.2 μm.
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Immunofluorescent images of vinculin (FITC-green), cytoskeletal actin (TRITC-red) and 
nucleus-staining (DAPI-blue) for MC3T3 cells on Flat Ti, 40nm TNTs and 120nm TNTs. 
(A) Magnification of 10× (Scale bars = 200 μm), (B) Magnification of 20× (Scale bars = 50 
μm), (C) Cell area and elongation vs. nanotube size. The bar graphs show the average ± 
standard error bars. Statistical significance (p < 0.05) are marked on the graphs with *.
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(A) Flow cytometry analysis of MC3T3-E1 cell cycle on different substrates after 24h 
culture, (B) Percentage of MC3T3-E1 cells in G1, S and G2 phases on different substrates. 
The statistical significance (p < 0.05) after performing t-tests are marked: *, indicates a 
significant difference between the same phase of the cells growing on different substrates, 
compared with Flat Ti.
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(A) Immunofluorescent images of BrdU-labeled nuclei (imerged image of TRITC-red and 
DAPI-blue) for MC3T3-E1 cells after one day culture. Scale bars = 200 μm. a. control group 
(regular medium), b. Regular medium + PF573228, c. Regular medium + C3 and d. Regular 
medium+ C3 + PF573228. (B) Quantification of BrdU-labeled nuclei for Day 1 and Day 7 
culture. The statistical significance (p < 0.05) after performing t-tests are marked: *, 
indicates a significant difference between the cells growing on different substrates with 
same treatment and at the same time point, compared with Flat Ti; #, denotes a significant 
difference between different time points on the same substrate and with same treatment, 
compare with D1.
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(A) Protein expression level of FAK, pY397-FAK and RhoA in MC3T3-E1 cells after one 
day culture on different substrates, (B) Densitometric quantification of total FAK, (C) 
Densitometric quantification of pY397-FAK, (D) RhoA activity level detected with G-
LISA™ assay, (E) Densitometric quantification of RhoA and (F) Densitometric 
quantification of RhoA/FAK. Values are expressed as means ± SD. * Significant difference 
in protein expression of cells on different substrats (p < 0.05).
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Gene expression of osteoblast markers in MC3T3-E1 cells after 4, 7, 14 and 21 days of 
culture. Fold change of Runx2, BSP, Osx and OCN (p < 0.05). * indicates a significant 
difference between different substrates.
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Table 1
qRT-PCR Primers.
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Table 2
Parameter estimates of non-linear regression analysis.
Term Estimate Std Error t Ratio Prob>|t|
Intercept 0.1486073 0.037882 3.92 0.0044*
FAK 0.0230961 0.06212 0.37 0.7197
RhoA −0.046325 0.037728 −1.23 0.2544
RhoA/FAK 0.0508234 0.015633 3.25 0.0117*
*
Significant difference P < 0.05.
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